Reply to Bernard Tombal's letter to the editor re: Alessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al. Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials. Eur Urol 2013;64:722-30

Eur Urol. 2014 Apr;65(4):e57. doi: 10.1016/j.eururo.2013.12.015. Epub 2013 Dec 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal